Name changes in medically important fungi and their implications for clinical practice.

G Sybren de Hoog, Vishnu Chaturvedi, David W Denning, Paul S Dyer, Jens Christian Frisvad, David Geiser, Yvonne Gräser, Josep Guarro, Gerhard Haase, Kyung-Joo Kwon-Chung, Jacques F Meis, Wieland Meyer, John I Pitt, Robert A Samson, John W Taylor, Kathrin Tintelnot, Roxana G Vitale, Thomas J Walsh, Michaela Lackner, Teun Boekhout (Collaborator)Arunaloke Chakrabarti (Collaborator), Anuradha Chowdhary (Collaborator), Garry Cole (Collaborator), Olivier A Cornely (Collaborator), Pedro W Crous (Collaborator), Christophe D'Enfert (Collaborator), Dea Garcia-Hermoso (Collaborator), D David Ellis (Collaborator), Cornelia Lass-Flörl (Collaborator), Stuart Levitz (Collaborator), Ruo-Yu Li (Collaborator), Aaron P Mitchell (Collaborator), Kerry O'Donnell (Collaborator), John R Perfect (Collaborator), Flavio Queiroz Telles (Collaborator), Deanna A Sutton (Collaborator), Kerstin Voigt (Collaborator), Theodore C White (Collaborator), Liyan Xi (Collaborator)

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Recent changes in the Fungal Code of Nomenclature and developments in molecular phylogeny are about to lead to dramatic changes in the naming of medically important molds and yeasts. In this article, we present a widely supported and simple proposal to prevent unnecessary nomenclatural instability.
    Original languageEnglish
    JournalJournal of clinical microbiology
    Volume53
    Issue number4
    DOIs
    Publication statusPublished - Apr 2015

    Fingerprint

    Dive into the research topics of 'Name changes in medically important fungi and their implications for clinical practice.'. Together they form a unique fingerprint.

    Cite this